FDA Inspection 1076023 — Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
The FDA completed an inspection of Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. on Nov 16, 2018 in Wuhan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 16, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wuhan (China)